Jump to main content
Jump to site search

Issue 8, 2016
Previous Article Next Article

Insights into solute carriers: physiological functions and implications in disease and pharmacokinetics

Author affiliations

Abstract

A major revision of the importance of solute carrier (SLC) transporters in human physiology and pathology has taken place in recent years. SLCs comprise the largest family of transporters, and there is significant evidence of their implication in health and several pathologies, leading to a growing interest in these transporters as novel targets for drug discovery. Since SLCs transport a broad range of endogenous and exogenous compounds, including drugs, they are the basis of significant drug–drug interactions and can cause potential drug toxicity or a lack of efficacy. This review compiles the up-to-date knowledge on the natural occurrence of the principal SLC families in human organs and tissues, in particular, highlighting their biological function and dysfunction in disease. Moreover, SLC implications in pharmacokinetics and drug–drug interactions are reviewed, concepts that can be useful in drug design.

Graphical abstract: Insights into solute carriers: physiological functions and implications in disease and pharmacokinetics

Back to tab navigation

Publication details

The article was received on 02 Apr 2016, accepted on 06 May 2016 and first published on 11 May 2016


Article type: Review Article
DOI: 10.1039/C6MD00188B
Med. Chem. Commun., 2016,7, 1462-1478

  •   Request permissions

    Insights into solute carriers: physiological functions and implications in disease and pharmacokinetics

    M. Estudante, G. Soveral, J. G. Morais and L. Z. Benet, Med. Chem. Commun., 2016, 7, 1462
    DOI: 10.1039/C6MD00188B

Search articles by author

Spotlight

Advertisements